Clinical Trial Update: A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy [Phase 1, Phase 2]

View source ↗

Summary

This document updates a Phase 1/Phase 2 clinical trial evaluating CAR-T cell therapy combined with interventional therapy for advanced liver malignancies, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Shanghai GeneChem Co., Ltd. | Conditions: Carcinoma, Hepatocellular, Pancreatic Cancer Metastatic | Phase 1, Phase 2 | Status: UNKNOWN